Synthesis, Biological Activity, and Computational Study of 1-[5-(4-Methylthiazol-5-yl)-2-phenyl-1,3,4-oxadiazol-3(2H)-yl]ethanone Derivatives
作者:Nirmala R. Darekar、Sushama J. Takate、Hemant N. Akolkar、Mubarak H. Shaikh、Vijay M. Khedkar、Bhausaheb K. Karale、Sadhana D. Mhaske
DOI:10.1134/s1070363222080199
日期:2022.8
Abstract A simple and efficient method of synthesis of 1-[5-(4-methylthiazol-5-yl)-2-phenyl-1,3,4-oxadiazol-3(2H)-yl]ethanone from (E)-N′-benzylidene-4-methylthiazole-5-carbohydrazides and acetic anhydride has been developed. Structures of the synthesized compounds have been confirmed by IR, 1H and 13C NMR, and mass spectra. All compounds have been tested for their in vitro antibacterial and antifungal
摘要 ( E ) -N合成1-[5-(4-甲基噻唑-5-基)-2-苯基-1,3,4-恶二唑-3( 2H )-基]乙酮的简单高效方法已经开发了'-亚苄基-4-甲基噻唑-5-碳酰肼和乙酸酐。合成化合物的结构已通过 IR、1 H 和13确认C NMR和质谱。所有化合物都经过体外抗菌和抗真菌活性测试。为了更深入地了解抗菌作用和预测这些化合物的结合模式,已经进行了分子对接研究。计算机 ADMET 预测和药代动力学研究证实了产品的高口服生物利用度。体外和计算机研究的结果表明,噻唑和恶二唑结合的杂环可以满足进一步开发新型治疗剂的结构要求。